Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Li, Chang  [Clear All Filters]
2018
Wang H, Georgakopoulou A, Psatha N, Li C, Capsali C, Samal HBhusan, Anagnostopoulos A, Ehrhardt A, Izsvák Z, Papayannopoulou T, et al. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. J Clin Invest. 2018.
2019
Wang H, Liu Z, Li C, Gil S, Papayannopoulou T, Doering CB, Lieber A. High-level protein production in erythroid cells derived from in vivo transduced hematopoietic stem cells. Blood Adv. 2019;3(19):2883-2894.
2020
Li C, Wang H, Georgakopoulou A, Gil S, Yannaki E, Lieber A. In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model. Mol Ther. 2020.
2021
Li C, Goncalves KA, Raskó T, Pande A, Gil S, Liu Z, Izsvák Z, Papayannopoulou T, Davis JC, Kiem H-P, et al. Single-dose MGTA-145/plerixafor leads to efficient mobilization and in vivo transduction of HSCs with thalassemia correction in mice. Blood Adv. 2021;5(5):1239-1249.
2023
Wang R, Wang Y, Niu Y, He D, Jin S, Li Z, Zhu L, Chen L, Wu X, Ding C, et al. Deep Learning-Predicted Dihydroartemisinin Rescues Osteoporosis by Maintaining Mesenchymal Stem Cell Stemness through Activating Histone 3 Lys 9 Acetylation. ACS Cent Sci. 2023;9(10):1927-1943.
Li J, Weng H, Liu S, Li F, Xu K, Wen S, Chen X, Li C, Nie Y, Liao B, et al. Embryonic exposure of polystyrene nanoplastics affects cardiac development. Sci Total Environ. 2023:167406.
Li C, Georgakopoulou A, Newby GA, Chen PJ, Everette KA, Paschoudi K, Vlachaki E, Gil S, Anderson AK, Koob T, et al. In vivo HSC prime editing rescues Sickle Cell Disease in a mouse model. Blood. 2023.
Qu C, Guan X, Li C, Zhu X, Ma T, Li H, Yu B, Yang H. Sesquiterpene lactones improve secretory diarrhea symptoms by inhibiting intestinal Ca-activated Cl channel activities directly and indirectly. Eur J Pharmacol. 2023:175917.